ACL Reconstruction – An Analysis of Effectiveness, Market Share, and Ongoing Trials .
ACL injuries are among the most feared in sports, with long recoveries and lasting instability. With up to half of patients developing osteoarthritis, these injuries place a heavy burden on individuals and health systems. Reconstruction remains the most common approach, and analysis of the literature shows it can offer better functional outcomes and fewer overall adverse events than rehabilitation alone—though pain, disease-specific scores, and re-injury rates appear similar between treatments. Market data highlight Smith & Nephew as the leading force in ACL reconstruction research, while global trials continue to expand rapidly. As new studies emerge, understanding the evolving evidence is key to optimizing treatment decisions and identifying where reconstruction truly offers an advantage.
Unlock the Full original article
You have access to 4 more FREE articles this month.
Click below to unlock and view this original article
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics